After fiery hearing, Purdue Pharma gets two-week break from opioid lawsuits

As published on Legal Newsline: WHITE PLAINS, N.Y., Oct. 14, 2019 – The federal bankruptcy judge overseeing Purdue Pharma’s Chapter 11 bankruptcy reorganization granted the OxyContin manufacturer and its controlling Sackler family a two-week respite from opioid litigation to work on a settlement that appeases warring state attorneys general and Read more…